84 results
8-K
EX-10.1
NBSE
NeuBase Therapeutics Inc
26 Jan 24
Entry into a Material Definitive Agreement
8:00am
and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.
(d) Notices. Any and all notices or other
8-K
EX-4.1
NBSE
NeuBase Therapeutics Inc
18 Oct 23
Entry into a Material Definitive Agreement
8:00am
, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced … with the investigation, preparation and prosecution of such action or proceeding.
f) Restrictions. The Holder acknowledges that the Warrant Shares acquired
8-K
EX-10.1
NBSE
NeuBase Therapeutics Inc
18 Oct 23
Entry into a Material Definitive Agreement
8:00am
and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.
(d) Notices. Any and all notices or other
S-1
EX-5.1
NBSE
NeuBase Therapeutics Inc
28 Jul 23
IPO registration
6:03am
and in rendering the opinion expressed below, we have assumed, without independent investigation or verification: (i) the genuineness of all signatures … , and as to the materiality of any fact or other matter referred to herein, we have relied (without independent investigation or verification) upon
8-K
EX-10.3
NBSE
NeuBase Therapeutics Inc
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning of the Securities Act. The Company shall not file … the Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified person
8-K
EX-5.1
fm6ypm0dwqzyc2blpmj
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
8-K
EX-10.2
03i0ynf
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
8-K
EX-10.1
4cfb0x vm
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
424B5
bi95da6ynd b4uamyvy1
30 Jun 23
Prospectus supplement for primary offering
8:42am
424B5
kpj5k94u6v ivcu2bwv
29 Dec 22
Prospectus supplement for primary offering
5:03pm
8-K
EX-10.1
rdsjf2l2
29 Dec 22
Entry into a Material Definitive Agreement
4:06pm
S-8
EX-5.1
4iqxr7tn
8 Apr 22
Registration of securities for employees
4:53pm
8-K
EX-10.1
nj9rumodnzki3q2
1 Oct 21
Departure of Directors or Certain Officers
4:17pm
424B5
tv7p16gs2rkood5 da5
27 Aug 21
Prospectus supplement for primary offering
5:21pm
8-K
EX-5.1
dgo5d bgwp
27 Aug 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
lapdswx 4afndh2034do
27 Aug 21
Entry into a Material Definitive Agreement
12:00am